within Pharmacolibrary.Drugs.ATC.M;

model M01AX24
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 0.00016666666666666666,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AX24</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxaceprol is an anti-inflammatory drug that is a derivative of proline. It was mainly used for the treatment of osteoarthritis to reduce joint inflammation and pain. The drug is not widely approved today and has largely been replaced by other nonsteroidal anti-inflammatory drugs (NSAIDs) in routine clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adults following oral administration based on sparse information from secondary pharmacological sources. No detailed compartmental model or exact PK parameters reported in published literature.</p><h4>References</h4><ol><li><p>Lachmann, G, et al., &amp; Kusche, W (1990). Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administration. <i>Arzneimittel-Forschung</i> 40(2 Pt 1) 200–206. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2334462/\">https://pubmed.ncbi.nlm.nih.gov/2334462</a></p></li><li><p>Alarçin, E, et al., &amp; Bal-Ozturk, A (2020). Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritis. <i>Drug development research</i> 81(4) 501–510. DOI:<a href=\"https://doi.org/10.1002/ddr.21642\">10.1002/ddr.21642</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31958153/\">https://pubmed.ncbi.nlm.nih.gov/31958153</a></p></li><li><p>Pawar, HS, et al., &amp; Mitra, A (2018). Comparative evaluation of therapeutic efficacy of intra-articular oxaceprol with conventional modalities in osteoarthritis animal model. <i>Clinical rheumatology</i> 37(8) 2195–2201. DOI:<a href=\"https://doi.org/10.1007/s10067-018-4087-1\">10.1007/s10067-018-4087-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29637484/\">https://pubmed.ncbi.nlm.nih.gov/29637484</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AX24;
